Стентування основного стовбура лівої коронарної артерії: технічні підходи і результати втручань 

С.М. Фуркало

Література

1. Athappan G., Patvardhan E., Tuzcu M.E. et al. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting // JACC Cardiovasc Interv.– 2013.– Vol. 6 (12).– P. 1219–1230.
2. Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis // J. Am. Coll. Cardiol.– 2002.– Vol. 39.– P. 1151–1158.
3. Boden W.E., O’Rourke R.A., Teo K.K. et al. Optimal medical therapy with or without PCI for stable coronary disease // New Engl. J. Med.– 2007.– Vol. 356.– P. 1503–1516.
4. Bucher H.C., Hengstler P., Schindler C., Guyatt G.H. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials // BMJ.– 2000.– Vol. 321.– P.73–77.
5. Caracciolo E.A., Davis K.B., Sopko G. et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience // Circulation.– 1995.– Vol. 91.– P.2335–2344.
6. Chen S.L., Santoso T., Zhang J.J. et al. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial // J. Interv. Cardiol.– 2001.– Vol. 14 (6).– P. 573–585.
7. Chen S.L., Xu B., Han Y.L. et al. Comparison of double kissing crush versus сulotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study // J. Am. Coll. Cardiol.– 2011.– Vol. 57 (8).– P. 914–920.
8. Collins N., Dzavik V. A modified balloon crush approach improves side branch access and side branch stent apposition during crushstenting of coronary bifurcation lesions // Catheter Cardiovasc. Interv. – 2004.– Vol. 63 (4).– P. 412–416.
9. Dores H., Raposo L., Almeida M.S. et al. Percutaneous coronary intervention of unprotected left main disease: Five-year outcome of a single-center registry // Rev. Port Cardiol.– 2013.– Vol. 32 (12).– P. 997–1004.
10. Farooq V., Serruys P.W., Zhang Y. et al. Short-Term and Long- Term Clinical Impact of Stent Thrombosis and Graft Occlusion in the SYNTAX Trial at 5Years: Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial // J. Am. Coll. Cardiol.– 2013.– Vol. 62 (25).– P. 2360–2369.
11. Нueb W., Lopes N.H., Gersh B.J. et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease // Circulation.– 2007.– Vol. 115.– P. 1082–1089.
12. Katritsis D.G., Ioannidis J.P. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis // Circulation.– 2005.– Vol. 111.– P. 2906–2912.
13. Lefèvre T., Louvard Y., Morice M.C. et al. Stenting of bifurcation lesions: a rational approach // Catheter. Cardiovasc. Interv.– 2006.– Vol. 68 (3).– P. 365–371.
14. Lim P.O., Dzavík V. Balloon crush: treatment of bifurcation lesions using the crush stenting technique as adapted for transradial approach of percutaneous coronary intervention // Catheter. Cardiovasc. Interv.– 2003.– Vol. 60 (2).– P. 145–151.
15. Min S.Y., Park D.W., Yun S.C. et al. Major predictors of long-term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: analysis from the MAIN-COMPARE study // Circ. Cardiovasc. Interv.– 2010.– Vol. 3.– P. 127–133.
16. Malenka D.J., Leavitt B.J., Hearne M.J. et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England // Circulation.– 2005.– Vol. 112.– P. I371–I376.
17. Naik H., White A.J., Chakravarty T. et al. A meta-analysis of 3,773 patients treated with percuta- neous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv 2009.– Vol. 2.– P. 739–747.
18. Park D.W., Seung K.B., Kim Y.H. et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry // J. Am. Coll. Cardiol.– 2010.– Vol. 56.– P. 117–124.
19. Schomig A., Mehilli J., de Waha A. et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease // J. Am. Coll. Cardiol.– 2008.– Vol. 52.– P. 894–904.
20. Serruys P.W., Morice M.C., Kappetein A.P. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease // N. Engl. J. Med.– 2009.– Vol. 360.– P. 961–972.
21. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). EHJ (2010) Vol. 31.– P. 2501–2555.
22. Yusuf S., Zucker D., Peduzzi P. et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration // Lancet.– 1994.– Vol. 344.– P. 563–570.

Поліпшення результатів аортокоронарного шунтування за допомогою додаткового захисту міокарда 

Б.М. Тодуров, Г.І. Ковтун, С.О. Шелудько

Література

1. Возианов А.Ф. Смертность населения Украины основные причины, пути преодоления негативных тенденций // Журн. АМН Украины.– 1996.– Т. 2, № 2.– С. 191–198.
2. Информационный бюллетень ВОЗ N°317 (март, 2013 г.)
3. Кнышов Г.В., Бендет Я.А. и др. Неотложные задачи кардиохирургии в Украине // Тез. докл. 4-й научной конференции Ассоциации сердечно-сосудистых хирургов Украины.– К., 1996.– С. 92–95.
4. Либанова Э., Левчук Н., Рудницкий Е. и др. Смертность населения Украины в трудоактивном возрасте (25–64 года) // Демоскоп.– 2009.– № 403.
5. Сердечно-сосудистая хирургия: Руководство / Под ред. В.И. Бураковского, Л.А. Бокерия.– М.: Медицина, 1996.– 688 с.
6. Ashraf S.S., Tian Y., Zacharrias S. et al. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles // Eur. J. Cardiothorac. Surg.– 1997.– Vol. 12.– P. 862–868.
7. Davies M.J., Nguyen K., Gaynor J.W. et al. Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg.– 1998.– Vol. 115.– P. 361–369.
8. ESC guidelines on the managementof stable coronary artery disease // Eur. Heart J.– 2013.
9. Finn A., Naik S., Klein N. et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg.– 1993.– Vol. 105.– P. 234–241.
10. Seghaye M.C., Grabitz R.G., Duchateau J. et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations // J. Thorac. Cardiovasc. Surg.– 1996.– Vol. 112.– P. 687–697.
11. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology // Eur. Heart J.– 2013.– August 30.

Изолированный дивертикул левого желудочка у ребенка 

И.А. Аксенова, Б.М. Тодуров,В.Ю. Вашкеба, Н.А. Озерянский,М.В. Хартанович, Р.В. Калашникова,Е.Н. Дудко, Б.В. Бацак

Література

1. Roessler W. Erfolgreiche operative Entfernung eines ektopischenHerzdivertikels an einem Neugeborenen // Dtsch. Z.Chir.– 1944.– Vol. 258.– Р. 261–270.
2. Shauq A., Agarwal V., Crawley C. Congenital left ventriculardiverticulum // Heart Lung Circ.– 2006.– Vol. 15.– P. 272–274.
3. Yi Ji., Wen-ying Liu, Lin Zhong, Chang Xu. Isolated finger-likeleft ventricular diverticulum in a stable boy // Сirculation.–2009.– Vol. 119.– P. 2951–2954.

 Альманах-2013: новітні некоронарні кардіохірургічні втручання

P. Meier, O. Franzen, A.J. Lansky

Література

1. Abdel-Wahab M., Zahn R., Horack M. et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry // Heart .. 2011.. 97.. P. 899.906.
2. Agnihotri A. 2012 ACCF/AATS/SCAI/STS expert consensus ocument on transcatheter aortic valve replacement: executive summary // J. Thorac. Cardiovasc. Surg.. 2012.. 144.. P. 534.537.
3. Alfieri O., Denti P. Alfieri stitch and its impact on mitral clip // Eur. J. Cardiothorac. Surg.. 2011.. 39.. P. 807.808.
4. Amat-Santos I.J., Dumont E., Villeneuve J. et al. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation // Heart.. 2012.. 98.. P. 1583.1590.
5. Astarci P., Glineur D., Kefer J. et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve // Eur. J. Cardiothorac. Surg.. 2011.. 40.. P. 475.479.
6. Bagur R., Manazzoni J.M., Dumont E. et al. Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis // Heart.. 2011.. 97.. P. 1687.1694.
7. Bass J.L. Transcatheter occlusion of the left atrial appendage. experimental testing of a new Amplatzer device // Catheter Cardiovasc. Interv.. 2010.. 76.. P. 181.185.
8. Binder R.K., Webb J.G. TAVI: from home-made prosthesis to global interventional phenomenon // Heart.. 2012.. 98.. P. iv30.36.
9. Bourantas C.V., Farooq V., Onuma Y. et al. Transcatheter aortic valve implantation: new developments and upcoming clinical trials // EuroIntervention.. 2012.. 8.. P. 617.627.
10. Camm A.J., Lip G.Y., De Caterina R. et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association // Eur. Heart J.. 2012.. 33.. P. 2719.2747.
11. Delgado V., Kapadia S., Marsan N.A. et al. Multimodality imaging before, during, and after percutaneous mitral valve repair // Heart.. 2011.. 97.. P. 1704.1714.
12. Dworakowski R., Wendler O., Bhan A. et al. Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction // Heart.. 2012.. 98.. P. 1641.1646.
13. Dworakowski R., Wendler O. Optimal pain management after aortic valve implantation: an opportunity to improve outcomes after transapical access in the future? // Heart .. 2012.. 98.. P. 1541.1542.
14. Esler M.D., Krum H., Schlaich M. et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial // Circulation.. 2012.. 126.. P. 2976.2982.
15. Esler M.D., Krum H., Sobotka P. A. et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomized controlled trial // Lancet.. 2010.. 376.. P. 1903.1909.
16. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm A.J. et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) // Eur. Heart J.. 2010.. 31.. P. 2369.2429.
17. Ewen S., Ukena C., Bohm M. et al. Percutaneous renal denervation: new treatment option for resistant hypertension and more? // Heart.. 2013.
18. Fairbairn T.A., Mather A.N., Bijsterveld P. et al. Diffusionweighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status // Heart.. 2012.. 98.. P. 18.23.
19. Feldman T., Foster E., Glower D.D. et al. Percutaneous repair or surgery for mitral regurgitation // New Engl. J. Med.. 2011.. 364.. P. 1395.1406.
20. Feldman T., Kar S., Rinaldi M. et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort // J. Am. Coll. Cardiol.– 2009.– 54.– P. 686–694.
21. Feldman T., Wasserman H.S., Herrmann H.C. et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial // J. Am. Coll. Cardiol.. 2005.. 46.. P. 2134.2140.
22. Fox B.D., Kahn S.R., Langleben D. et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials // BMJ.. 2012.. Vol. 345.. P. e7498.
23. Gaemperli O., Moccetti M., Surder D. et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes // Heart.. 2012.. 98.. P. 126.132.
24. Gallagher A.M., Rietbrock S., Plumb J. et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? // J. Thromb. Haemost.. 2008.. 6.. P. 1500.1506.
25. Garcia-Fernandez M.A., Perez-David E., Quiles J. et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study // J. Am. Coll. Cardiol.. 2003.. Vol. 42.. P. 1253.1258.
26. Grant S.W., Devbhandari M.P., Grayson A.D. et al. What is the impact of providing a transcatheter aortic valve implantation service on conventional aortic valve surgical activity: patient risk factors and outcomes in the first 2 years // Heart.. 2010.. Vol. 96.. P. 1633.1637.
27. Gripari P., Ewe S.H., Fusini L. et al. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation // Heart.. 2012.. 98.. P. 1229.1236.
28. Hahn R.T., Pibarot P., Stewart W.J. et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echo parameters in cohort A of the PARTNER trial // J. Am. Coll. Cardiol.. 2013.. 61.. P. 2514.2521.
29. Hering D., Mahfoud F., Walton A.S. et al. Renal denervation in moderate to severe CKD // J. Am. Soc. Nephrol.. 2012.. 23.. P. 1250.1257.
30. Holmes D.R., Reddy V.Y., Turi Z.G. et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial // Lancet.. 2009.. 374.. P. 534. 542.
31. Investigators S.H. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension.. 2011.. 57.. P. 911.917.
32. Iung B., Vahanian A. Degenerative calcific aortic stenosis: a natural history // Heart .. 2012.. 98.. P. iv7.13.
33. Kar S., Rinaldi M., Lim D.S. et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: demographics and procedural outcomes. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
34. Kempny A., Diller G..P., Kaleschke G. et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function // Heart.. 2012.. 35. Khattab A.A., Meier B. Transcatheter left atrial appendage exclusion, gold or foolЃfs gold? // Eur. Heart J.. 2010.. 12 (Suppl.). P. E35.40.
36. Krum H., Schlaich M., Whitbourn R. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study // Lancet.. 2009.. 373.. P. 1275.1281.
37. Lloyd-Jones D.M., Wang T.J., Leip E.P. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study // Circulation.. 2004.. 110.. P. 1042.1046.
38. Malaisrie S.C., Tuday E., Lapin B. et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis // Eur. J. Cardiothorac. Surg.. 2011.. 40.. P. 43.48.
39. Massumi A., Chelu M.G., Nazeri A. et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation // Am. J. Cardiol.. 2013.. 111.. P. 869.873.
40. Meier P., Timmis A. Almanac 2012: interventional cardiology // Anadolu Kardiyol Derg.. 2012.. 13.. P. 91.101.
41. Meier P., Timmis A. Almanac 2012: interventional cardiology: the national society journals present selected research that has driven recent advances in clinical cardiology // Heart.. 2012.. 98.. P. 1701.1709.
42. MEMBERS W.C., Bonow R.O., Carabello B.A. et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons // Circulation.. 2008.. 118.. P. e523.661.
43. Mesa D., Castillo F., Ruiz Ortiz M. et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function // Heart.. 2013.. 99.. P. 286.
44. Munkholm-Larsen S., Cao C., Yan T.D. et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review // Heart.. 2012.. 98.. P. 900.907.
45. Mussardo M., Latib A., Chieffo A. et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve // JACC Cardiovasc. Interv.. 2011.. 4.. P. 743.750.
46. Naber C.K., Ghanem A., Abizaid A.A. et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation // EuroIntervention.. 2012.. 8.. P. 43.50.
47. Neragi-Miandoab S., Skripochnik E., Michler R.E. Recently patented and widely used valves for transcatheter aortic valve implantation // Recent Pat Cardiovasc. Drug Discov.. 2012.. 7.. P. 196.205.
48. Nietlispach F., Wijesinghe N., Gurvitch R. et al. An embolic deflection device for aortic valve interventions // JACC Cardiovasc. Interv.. 2010.. 3.. P. 1133.1138.
49. Nkomo V.T., Gardin J.M., Skelton T.N. et al. Burden of valvular heart diseases: a population-based study // Lancet.. 2006.. 368.. P. 1005.1011.
50. Onsea K., Agostoni P., Samim M. et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions // EuroIntervention.. 2012.. 8.. P. 51.56.
51. Piazza N., Grube E., Gerckens U. et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval // EuroIntervention.. 2008.. 4.. P. 242.249.
52. Prendergast B.D., Naber C.K., Popma J.J. Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development // Heart.. 2012.. 98.. P. iv37.43.
53. Reddy V.Y., Doshi S.K., Sievert H. et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial // Circulation.. 2013.. 127.. P. 720.729.
54. Reddy V.Y., Holmes D., Doshi S.K. et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry // Circulation.. 2011.. 123.. P. 417.424.
55. Rinaldi M.J., Kar S., Lim D.S. et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: analysis of a 6 month patient cohort. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
56. Rosenhek R. Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology // Heart .. 2011.. 97.. P. 2007.2017.
57. Samad Z., Kaul P., Shaw L.K. et al. Impact of early surgery on survival of patients with severe mitral regurgitation // Heart.. 2011.. 97.. P. 221.224.
58. Sarkar K., Ussia G.P., Cammalleri V. et al. Quality of life of high risk patients following percutaneous mitral valve repair with the MitraClip system. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.. Baltimore, 2011.
59. Schofer J. REDUCE-HTN trial.. Paris: Euro PCR, 2013.
60. Sinning J..M., Werner N., Nickenig G. et al. Transcatheter aortic valve implantation: the evidence // Heart.. 2012.. 98.. P. iv65.72.
61. Sousa J.E., Costa M.A., Tuzcu E.M. et al. New frontiers in interventional cardiology // Circulation.. 2005.. 111.. P. 671.681.
62. Stortecky S., Buellesfeld L., Wenaweser P. et al. Transcatheter aortic valve implantation: the procedure // Heart.. 2012.. 98.. P. iv44.51.
63. Surder D., Pedrazzini G., Gaemperli O. et al. Predictors for efficacy of percutaneous mitral valve repair using the
MitraClip system: the results of the MitraSwiss registry // Heart.. 2013.. 99.. P. 1034.1040.
64. Svensson L.G., Tuzcu M., Kapadia S. et al. A comprehensive review of the PARTNER trial // J. Thorac. Cardiovasc. Surg.. 2013.. 145.. P. S11.16.
65. Tamburino C., Capodanno D., Ramondo A. et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis // Circulation.. 2011.. 123.. P. 299.308.
66. Tamburino C., Ussia G.P., Maisano F. et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting // Eur. Heart J.. 2010.. 31.. P. 1382.1389.
67. Templin C., Jaguszewski M., Ghadri J.R. et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN. multi-electrode renal denervation catheter // Eur. Heart J.. 2013 Apr 25. [Epub ahead of print] doi:10.1093/eurheartj/eht141
68. Thomas M., Schymik G., Walther T. et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve // Circulation.. 2011.. 124.. P. 425.343.
69. Thomas M., Schymik G., Walther T. et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN Valve // Circulation.. 2010.. 122.. P. 62.69.
70. Viles-Gonzalez J.F., Kar S., Douglas P. et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy // J. Am. Coll. Cardiol.. 2012.. 59.. P. 923.929.
71. Watt M., Mealing S., Eaton J. et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement // Heart.. 2012.. 98.. P. 370.376.
72. Whitlow P.L., Feldman T., Pedersen W.R. et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study // J. Am. Coll. Cardiol.. 2012.. 59.. P. 130.139.
73. Worthley S.G. EnligHTN-1: BP drops durable, safe at one year, as renal-denervation mania grows. EuroPCR.. Paris: Heartwire, 2013.

Роль черезстравохідної ехокардіографії в діагностиці абсцесу аортомітрального контакту

І.Б. Харкава, Н.В. Понич, О.А. Єпанчінцева, О.Й. Жарінов, Б.М. Тодуров

Література

1. Bannay A., Hoen B., Duval X. et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? // Eur. Heart J.– 2011.– Vol. 32.– P. 2003–2015.
2. Beynon R.P., Bahl V.K., Prendergast B.D. Infective endocarditis // Brit. Med. J.– 2006.– P. 468.
3. Duval X., Delahaye F., Alla F. et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys // J. Am. Coll. Cardiol.– 2012.– Vol. 59.– P. 1968–1976.
4. Habib G., Badano L. Tribouilloy C. et al. Recommendations for the practice of echocardiography in infective endocarditis // Eur. J. Echocardiography.– 2010.– Vol. 11.– P. 202–219.
5. Osler W. The gulstonian lectures on malignant endocarditis // Br. Med. J.– 1885.– P. 467–470.
6. Perrino A.C., Jr., Reeves S.T. A practical approach to transesophageal echocardiography.– Lippincott Williams and Wilkins, 2008. – 493 p.
7. Tirone E.D., Gavra G., Feindel C.M. et al. Surgical treatment of active infective endocarditis: a continued challenge // J. Thorac. Cardiovasc. Surg.– 2007.– Vol. 133 (1).– P. 144–149.

 Вогнищеве ураження міокарда лівого шлуночка і ризик раптової смерті при саркоїдозі серця 

Н.Д. Орищин , Ю.А. Іванів , Н.В. Лозинська , О.Я. Сорока , С.С. Павлик , Ю.О. Паламарчук , М.С. Сороківський 

Література

1. Aizer A., Stern E.H., Gomes J.A. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis // Am. J. Cardiol.– 2005.– Vol. 96.– P. 276–282.
2. Cheong B.Y., Muthupillai R., Nemeth M. et al. The utility of delayed-enhancement magnetic resonance imaging for identifing non-ischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis // Vasc. Diffuse Lung Dis.– 2009 – Vol. 26.– P. 39–46.
3. Epstein A.E., DiMarco J.P., Ellenbogen K.A. et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. // J. Am. Coll. Cardiol.– 2008.– Vol. 51.– P. e1–62.
4. Evanchan J.P., Crouser E.D., Kalbfleisch S.J. Cardiac Sarcoidosis: Recent Advances in Diagnosis and Treatment and an Argument for the Need for a Systematic Multidisciplinary Approach to Management // J. Inn. Cardiac Rhythm Management.– 2013.– Vol. 4.– P. 1160–1174.
5. Hiraga H., Yuwai K., Hiroe M. et al. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases from the Japanese Ministry of Health and Welfare // Japanese Ministry of Health and Welfare.– 1993.– Р. 23–24.
6. Kato Y., Morimoto S., Uemura A. et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block // Sarcoidosis Vasc. Diffuse Lung Dis.– 2003.– Vol. 20.– P.133–137.
7. Mehta D., Lubitz S.A., Frankel Z et al. Cardiac involvement in patients with sarcoidosis // Chest.– 2008.– Vol. 133.– P. 1426–1435.
8. Mehta D., Mori N., Goldbarg S.H. et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: clinical perspective // Circ. Arrhythm. Electrophysiol.– 2011.– Vol. 4.– P. 43–48.
9. Patel M.R., Cawley P.J., Heitner J.F. et al. Detection of myocardial damage in patients with sarcoidosis // Circulation.– 2009.– Vol. 120.– P. 1969–1977.
10. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11) // Am. J. Med.– 1977.– Vol. 63.– P. 86–108.
11. Smedema J.P., Snoep G., van Kroonenburgh M.P. et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis // J. Am. Coll. Cardiol.– 2005.– Vol. 45.– P. 1683–1690.
12. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities // J. Cardiovasc. Electrophysiol.– 2009.– Vol. 20.– P. 578–583.
13. Tadamura E., Yamamuro M., Kubo S. et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging // Am. J. Roentgenol.– 2005.– Vol. 185.– P. 110–115.
14. Youssef G., Beanlands R.S., Birnie D.H. et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment // Heart.– 2011.– Vol. 97.– P. 2078–2087.
15. Yodogawa K., Seino Y., Ohara T. et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis // Ann. Noninvasive Electrocardiol.– 2011.– Vol. 16.– P. 140–147.

Незвичайний випадок злоякісного перебігу міксоми правого передсердя 

Р.М. Вітовський, В.В. Ісаєнко, О.В. Кривенький, І.Г. Яковенко, А.О. Антощенко, Є.О. Білинський, О.З. Парацій, Т.І. Дєдкова, Л.І. Чернякова

Література

1. Кнышов Г.В., Витовский Р.М., Захарова В.П. Опухоли сердца.– К., 2005.– 256 с.
2. Малашенков А.И., Кавсадзе В.Э. Хирургия опухолей сердца.– М., 2004.– 94 с.
3. Diaz A., Di Salvo C., Lawrence D., Hayward M. Left atrial and right ventricular myxoma: an uncommon presentation of a rare tumour // Interact. Cardiovasc. Thorac. Surg.– 2011.– Vol. 12, № 4.– P. 622–623.
4. Hill M., Cherry C., Maloney M., Midyette P. Surgical resection of atrial myxomas // AORN J.– 2010. − Vol. 92, № 4.– P. 393–406.
5. Neragi-Miandoab S., Kim J., Vlahakes G.J. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy // Clin. Oncol.– 2007.– Vol. 19 (10).– P. 748–756.
6. Nowak T., Stachurski A., Rachwalik M. et al. Big myxoma of the left atrium suggesting pulmonary embolism // Kardiol. Pol.– 2010. − Vol. 68, N 6.– P. 695–696.
7. Oliveira R., Branco L., Galrinho A. et al. Cardiac myxoma: a 13-year experience in echocardiographic diagnosis // Rev. Port. Cardiol.– 2010. − Vol. 29, N 7.– P. 1087–1100.
8. Park J., Song J.M., Shin E. et al. Cystic cardiac mass in the left atrium: hemorrhage in myxoma // Circulation.– 2011.– Vol. 123, N 10.– P. 368–369.
9. Shanmugam G. Primary cardiac sarcoma // Eur. J. Cardiothorac Surg.– 2006.– Vol. 29 (6).– P. 925–932.
10. Simpson L., Kumar S.K., Okuno S.H. et al. Malignant primary cardiac tumors: review of a single institution experience // Cancer.– 2008.– Vol. 112 (11).– P. 2440–2446.
11. Yavuz S., Eris C., Sezen M. et al. Recurrent multiple cardiac myxomas // Bratisl. Lek. Listy.– 2010.– Vol. 111, N 10.– P. 549–551.
12. Yuan S.M., Shinfeld A., Lavee J. et al. Imaging morphology of cardiac tumours // Cardiol J.– 2009.– Vol. 16 (1).– P. 26–35.

 Ургентна тромбемболектомія в пацієнта з гострою масивною тромбоемболією легеневої артерії 

М.Д. Глагола, В.Б. Демянчук, О.Г. Біцадзе, Н.В. Шателен, А.О. Максаков, Л.М. Максименко, С.М. Сагура, О.М. Фурса, Б.М. Тодуров

Література

1. Савельев В.С., Матюшенко А.А. Тромбоэмболия легочных артерий. Точка зрения хирурга // Грудная и сердеч.-сосуд. хирургия.– 1999.– № 6.– С. 6–11.
2. Тодуров Б.М. Опыт хирургического лечения массивной и субмассивной тромбоэмболии легочной артерии // Укр. кардіол. журн.– 2005.– № 1.– С. 69–72.
3. Тодуров Б.М. Опыт хирургического лечения острой тромбоэмболии ветвей легочной артерии и посттромбоэмболической легочной гипертензии // Серце і судини.– 2004.– № 1 (5).– С. 44–51.
4. Тодуров Б.М., Онищенко В.Ф., Сморжевский В.И. и др. Хирургическое лечение посттромбоэмболической легочной гипертензии // Клін. хірургія.– 2005.– № 4–5.– С. 64.
5. Bell W., Laske A., Segesser L. et al. Current status of pulmonary thrombo-embolic disease: pathophysiology, diagnosis, prevention and treatment // Am. Heart J.– 1982.– Vol. 103.– P. 239–248.
6. Doerge H.C., Schoendube F.A., Loeser H. et al. Pulmonary embolectomy: review of a 15 year experience and role in the age of thrombolytic therapy: early and late results // Thorac. Cardiovasc.– 1999.– Vol. 47.– P. 9–13.
7. Goldhaber S. Thrombolysis in pulmonary embolism: a debatable indication // Thromb. Haemost.– 2001.– Vol. 86.– P. 444–451.
8. Gray H., Morgan J., Paneth M. et al. Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases // Brit. Heart J.– 1988.– Vol. 60.– P. 196–200.
9. Gulba D.C., Schmid C., Borst H.G. et al. Medical compared with surgical treatment for massive pulmonary embolism // Lancet – 1994.– Vol. 343.– P. 576 –577.
10. Kadner A., Schmidli J., Schonhoff F. et al. Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients // J. Thorac. Cardiovasc. Surg.– 2008.– Vol. 124.– P. 448–451.
11. Leacche M., Unic D., Goldhaber S. Modern surgical treatment of massive pulmonary embolism: results of 47 consecutive patients after rapid diagnosis and aggressive surgical approach // J. Thorac. Cardiovasc. Surg.– 2005.– Vol. 129.– P. 1018–1023.
12. Meneveau N., Seronde M., Blonde M. et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism // Chest. – 2006.– Vol. 129.– P. 1043–1050.
13. Rosenberger P., Shernan S., Rawn J. et al. Critical role of inferior vena cava filter placement after pulmonary embolectomy // J. Card. Surg.– 2005.– Vol. 20.– P. 289–290.
14. Stulz P., Schlapfer R., Feer R. et al. Decision making in the surgical treatment of massive pulmonary embolism // Eur. J. Cardiothorac. Surg.– 1994.– Vol. 8.– P. 188–193.
15. Tapson V.F., Witty L.A. Massive pulmonary embolism // Clin. Chest Med.– 1995.– Vol. 16(2).– P. 281–294.
16. Vohra H., Whistance R., Mattam K. et al. Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism // Ann. Thorac. Surg.– 2010.– Vol. 90.– P. 1747–1752.
17. Yalamanchili K., Fleisher A.G., Lehrman S.G. et al. Open pulmonary embolectomy for treatment of major pulmonary embolism // Ann. Thorac. Surg.– 2004.– Vol. 77.– P. 819–823.

Сучасні підходи та методики трансплантації стовбурових клітин хворим з термінальною стадією серцевої недостатності

А.В. Габрієлян, Р.В. Салютін, А.В. Якушев, В.Ф. Оніщенко, В.М. Шаблій, Т.М. Доманський, І.В. Кудлай, С.В. Романова, О.І. Миронюк

Література

1. Горбась І.М. Ішемічна хвороба серця: епідеміологія і статистика // Здоров’я України.– 2009.–  №3/1.– C. 57–59.

2. Barbash I.M., Chouraqui P., Baron J. et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution // Circulation.– 2003 – Vol. 108, N 7.– Р. 863–868.

3. Bel A., Planat-Bernard V., Saito A. et al. Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells // Circulation.– 2010.– Vol. 122, N 11 (Suppl. 1).– Р. 118–123.

4. Chin B.B., Nakamoto Y., Bulte J.W.M. In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction // Nuclear Medicine Communications.– 2003.– Vol. 24, N 11.– Р. 1149–1154.

5. Copland B. Mesenchymal stromal cells for cardiovascular disease // J. Cardiovasc. Disease Research.– 2011.– Vol. 2, N 1.– Р. 3–13.

6. Dib N., Khawaja H., Varner S. et al. Cell therapy for cardiovascular disease: a comparison of methods of delivery // J. Cardiovasc. Translational Research.– 2011.– Vol. 4, N 2.– Р. 177–181.

7. Dib, P. Menasche, J.J. Bartunek et al. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research // JACC.– 2010.– Vol. 3, N 3.– Р. 265–275.

8. Dickstein K., Cohen-Solal A., Filippatos G. et al. ESC Committee for Practice Guidelines // Eur. J. Heart Fail.– 2008.– Vol. 10 (10).– P. 933-89.

9. Gavira J.J., Herreros J., Perez A. et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up // J. Thorac. Cardiovasc. Surgery.– 2006.– Vol. 131, N 4.– Р 799–804.

10. Grossman P.M., Han Z., Palasis M. et al. Incomplete retention after direct myocardial injection // Catheterization and Cardiovascular Interventions.– 2002.– Vol. 55, N 3.– Р. 392–397.

11. Hagège A.A., Marolleau J.-P., Vilquin J.-T. et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients // Circulation.– 2006.– Vol. 114, N 1.– Р. I108–I113.

12. Halkos M.E., Zhao Z.Q., Kerendi F. et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction // Basic Research in Cardiology.– 2008.– Vol. 103, N 6.– Р. 525–536.

13. Hare J.M., Traverse J.H., Henry T.D. et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction // J. Amer. Coll. Cardiology.– 2009.– Vol. 54, N 24.– Р. 2277–2286.

14. He J., Ogden L.G., Bazzano L.A. et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study // Arch. Intern. Medicine.– 2001.– Vol. 161, N 7.– Р. 996–1002.

15. Hofmann M., Wollert K.C., Meyer G.P. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium // Circulation.– 2005.– Vol. 111, N 17.– Р. 2198–2202.

16. Hou D., Youssef E.A.S., Brinton T.J. et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials // Circulation.– 2005.– Vol. 112 – № 9 (Suppl.).– Р. 150–156.

17. Kastrup J., Jørgensen E., Rück A. et al. Direct intramyocardial plasmid vascular endothelial growth factor-A 165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: the Euroinject One trial // J. Amer. Coll.    Cardiology.– 2005.– Vol. 45, N 7.– Р. 982–988.

18. Kim R.J., Wu E., Rafael A. et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction // New Engl. J. Medicine.– 2000.– Vol. 343, N 20.– Р. 1445–1453.

19. Li Z., Guo X., Palmer A.F. et al. High-efficiency matrix modulus-induced cardiac differentiation of human mesenchymal stem cells inside a thermosensitive hydrogel // Acta Biomaterialia.– 2012.– Vol. 8, N 10.– Р. 3586–3595.

20. Losordo D.W., Vale P.R., Hendel R.C. et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia // Circulation.– 2002.– Vol. 105,  N 17.– Р. 2012–2018.

21. Mozid M., Arnous S., Sammut E.C. et al. Stem cell therapy for heart diseases // British Medical Bulletin.– 2011.– Vol. 98, N 1.– Р. 143–159.

22. Patel A.N., Geffner L., Vina R.F. et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study // J. Thorac. Cardiovasc. Surgery.– 2005.– Vol. 130, N 6.– Р. 1631–1638.

23. Penn S., Ellis S., Gandhi S. et al. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase i clinical study // Circulation.– 2012.– Vol. 110, N 2.– Р. 304–311.

24. Perin E.C., Silva G.V., Assad J.A.R. et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction // J. Molecul. Cell. Cardiology.– 2008.– Vol. 44, N 3.– Р. 486–495.

25. Pompilio G., Steinhoff G., Liebold A. et al. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133⁺ stem cells in patients with refractory ischemia: preliminary results // Thorac. Cardiovasc. Surgeon.– 2008.– Vol. 56, N 2.– Р. 71–76.

26. Sacchetti A., Harris R.H., Sharon A. et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia // J. Am. Coll. Cardiol.– 2001.– Vol. 37, N 6.– Р. 1726–1732.

27. Schachinger V., Erbs S., Elsasser A. et al. Intracoronary bone marrow-derived  progenitor cells in acute myocardial infarction // New Engl. J. Med.– 2006.– Vol. 355.– P. 1210–1221. 

28. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease // Nature.– 2008.– Vol. 451.– P. 937–942.

29. Sherman W., Martens T.P., Viles-Gonzalez J.F. et al. Catheter-based delivery of cells to the heart // Nature Clin. Pract. Cardiovasc. Medicine.– 2006.– Vol. 3, N 1.– Р. 57–64.

30. Siminiak T., Fiszer D., Jerzykowska O. et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial // Eur. Heart J.– 2005.– Vol. 26, N 12.– Р. 1188–1195.

31. Siminiak T., Burchardt P., and Kurpisz M.. Postinfarction heart failure: surgical and trans-coronary-venous transplantation of autologous myoblasts // Nature Clin. Practice Cardiovasc. Medicine.– 2006.– Vol. 3, N 1.– Р. 46–51.

32. Sui R., Liao X., Zhou X. et al. The current status of engineering myocardial tissue // Stem Cell Reviews and Reports.– 2011.– Vol. 7 , N 1.– Р. 172–180.

33. Terrovitis J., Lautamäki R., Bonios M. et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery // J. Amer. Coll. Cardiology.– 2009.– Vol. 54, N 17.– Р. 1619–1626.

34. Thompson CA, Nasseri BA, Makower J, et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation // J. Am. Coll. Cardiol.– 2003.– Vol. 41.– Р. 1964–1971.

35. Thompson C.A., Nasseri B.A., Makower J. et al. Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation // J. Amer. Coll. Cardiology.– 2003.– Vol. 41, N 11.– Р. 1964–1971.

36. Vicario J., Campo C., Piva J. et al. One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina // Cardiovasc. Revascularization Medicine.– 2005.– Vol. 6,  N 3.– Р. 99–107.

37. Vicario J., Piva J., Pierini A. et al. Transcoronary sinus delivery of autologous bone marrow and angiogenesis in pig models with myocardial injury // Cardiovasc. Radiation Medicine.– 2002.– Vol. 3, N 2.– 91–94.

38. Won. J.K., Kang H.-J., Kim H.-S. et al. Tissue distribution of ¹⁸F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction // J. Nuclear Medicine.– 2006.– Vol. 47, N 8.– Р. 1295–1301.

39. Yokoyama S.I., Fukuda N., Li Y. et al. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease // J. Molec. Cell. Cardiology.– 2006.– Vol. 40, N 1.– Р. 24–34.